laparoscopic adrenalectomy
Procedureminimally invasive lateral transperitoneal adrenalectomy
NCT Number: NCT03830593
Laparoscopic adrenalectomy is the treatment of choice for the benign tumor of less than 6 cm. However, this is an ongoing debate that exact cut-off value of tumor size for LA. The aim of this study was to assess whether the size of the adrenal tumor affects preoperative and postoperative outcomes in patients undergoing laparoscopic transperitoneal adrenalectomy as well as to evaluate the learning curve.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Ondokuz Mayıs University, Samsun, Turkey (Türkiye)
From April 2010 to October 2018, preoperative and postoperative data of 107 patients who underwent LTA with adrenal mass were recorded prospectively and analyzed retrospectively.
The inclusion criteria were all hormonally active adrenal lesions, detection of increases in size in < 4 cm adrenal tumors on serial imaging, solitary adrenal metastases without evidence of local invasion, tumors size ≥ 4 cm, patients between the age of 18 and 80, and American Society of Anesthesiologists score (ASA) ≤ 3. The patients with adrenal masses that specified suspicion of malignancy on imaging such as local invasion, irregular tumor margins were evaluated as ineligible for LTA, and excluded in this study, were addressed to open surgery. Retroperitoneoscopic and laparoscopic partial adrenalectomies were also excluded from the study.
Totally 102 patients were included in the study. The patients were allocated according to adrenal tumor size as <6cm (group 1:76) and ≥ 6 cm (group 2: 26). The variables such as demographics, tumor size, and laterality, operation time, blood loss, per-operative and postoperative complications, length of hospital stay, final pathology result were compared between the two groups. In order to evaluate the learning curve, the patients were also classified into three consecutive groups including group A (1-25), group B (25-50), group C (51-75) and group D (76-102) according to the chronological order of their surgery. Variables including operation time, tumor size, blood loss, and hospital stay, and overall complications were used to investigate the learning curve.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
minimally invasive lateral transperitoneal adrenalectomy
Time frame: intraoperative (minute)
time from onset to complete of operation
Time frame: intraoperative
amount of bleeding during surgery (milliliter)
Time frame: 1 day
duration of postoperative hospital stay
Time frame: 1 day
abnormal conditions during or after surgery
Samsun Liv Hospital
Other
Is There Anything New in the Field of Large Adrenal Tumors ?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06330558
Adrenal Gland Diseases, Adrenal Gland Neoplasms
View Trial DetailsNCT04804163
Adenocarcinoma, Adrenal Gland Diseases
Qingdao, Shandong, China
View Trial DetailsNCT04570176
Adenocarcinoma, Adrenal Gland Diseases
Qingdao, Shandong, China
View Trial DetailsNCT04071561
Adrenal Cortex Diseases, Adrenal Cortex Neoplasms
Basel, Switzerland
View Trial Details